Previously, our group demonstrated that C3 mRNA expression was significantly increased in tumour biopsies of oesophageal adenocarcinoma patients with a subsequent poor response to neoadjuvant chemoradiotherapy (neo-CRT) [201]. This evidence concerns the gene C3 and esophageal adenocarcinoma.